Characterization of patient specific signaling via augmentation of Bayesian networks with disease and patient state nodes.
Characterization of patient-specific disease features at a molecular level is an important emerging field. Patients may be characterized by differences in the level and activity of relevant biomolecules in diseased cells. When high throughput, high dimensional data is available, it becomes possible to characterize differences not only in the level of the biomolecules, but also in the molecular interactions among them. We propose here a novel approach to characterize patient specific signaling, which augments high throughput single cell data with state nodes corresponding to patient and disease states, and learns a Bayesian network based on this data. Features distinguishing individual patients emerge as downstream nodes in the network. We illustrate this approach with a six phospho-protein, 30,000 cell-per-patient dataset characterizing three comparably diagnosed follicular lymphoma, and show that our approach elucidates signaling differences among them.
Sachs
Karen
K
Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford School of Medicine, USA.
Gentles
Andrew J
AJ
Youland
Ryan
R
Itani
Solomon
S
Irish
Jonathan
J
Nolan
Garry P
GP
Plevritis
Sylvia K
SK
D001499:Bayes Theorem; D004194:Disease; D006801:Humans; D008954:Models, Biological; D010750:Phosphoproteins / Q000378:metabolism; D015398:Signal Transduction
D010750:Phosphoproteins